Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: A case report

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 3, 1996, Pages 322-323

  Herbrecht, R ^a   Sosa, C ^a   Himy, R ^b   Villard, O ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Institut de Parasitologie et de Pathologie Tropicale   (France)

Author keywords

Amphotericin B; Chemotherapy; Fat emulsion; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; INTRALIPID; LIPID EMULSION;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG COST; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; SIDE EFFECT; VISCERAL LEISHMANIASIS;

EID: 0029903284     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90272-2     Document Type: Article

References (5)

1. Davidson, R. N. & Croft, S. L. (1993). Recent advances in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 130-131 & 141.
2. Mishra, M., Biswas, U. K., Jha, A. M. & Khan, A. B. (1994). Amphotericin versus sodium stibogluconate in first line treatment of Indian kala-azar. Lancet, 344, 1599-1600.
3. Thakur, C. P. (1994). Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kalaazar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 698-699.
4. Thakur, C. P., Sinha, G. P., Sharma, V., Pandey, A. K., Kumar, M. & Verma, B. B. (1993). Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian Journal of Medical Research, 97, 170-175.
5. Trissel, L. A. (1995). Amphotericin B does not mix with fat emulsion. American Journal of Health-System Pharmacy, 52, 1463-1464.